Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shen Pu Yang Gan Wan, also known as S.P.PRO LIVER POWDER, is a Traditional Chinese Medicine (TCM) botanical formulation developed or evaluated by Taipei Medical University WanFang Hospital. It is primarily investigated for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated metabolic disorders. The formula is designed to improve liver function, reduce liver fibrosis and stiffness (as measured by FibroScan), and optimize metabolic indexes, including liver enzymes (ALT/AST), blood glucose, and lipid profiles. It has been evaluated in Phase 4 clinical trials to assess its efficacy in improving liver and metabolic health in patients with fatty liver conditions, particularly those with metabolic syndrome components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shen Pu Yang Gan Wan.